Healthy volunteers test new way to deliver oxycodone
NCT ID NCT06500793
First seen Mar 11, 2026 · Last updated May 21, 2026 · Updated 18 times
Summary
This early-stage study in 30 healthy adults measures how the body processes oxycodone when given as a new formulation called PF614, alone or with another drug called nafamostat. The goal is to understand drug levels and safety, not to treat any condition. Results will guide future development of this pain medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Quotient Sciences
RECRUITINGMiami, Florida, 33126, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.